Svenska Handelsbanken Ab (Publ) Abb Vie Inc. Transaction History

Svenska Handelsbanken Ab (Publ)

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	BUY	$159.82 - $182.1 $29.2 Million - $33.3 Million	182,749 New	182,749 $33.3 Million
Q4 2021 Feb 03, 2022	SELL	$107.43 - $135.93 $276,954 - $350,427	-2,578 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$106.4 - $120.78 $274,299 - $311,370	2,578 New	2,578 $278,000
Q1 2019 May 07, 2019	SELL	$77.14 - $90.79 $794,542 - $935,137	-10,300 Closed	0 $0
Q2 2018 Jul 27, 2018	SELL	$89.78 - $106.23 $341,164 - $403,674	-3,800 Reduced 26.95%	10,300 $954,000
Q2 2017 Aug 08, 2017	BUY	N/A	14,100	14,100 $1.02 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Svenska Handelsbanken Ab (Publ), based on Form 13F filings with the SEC.

Stay updated on Svenska Handelsbanken Ab (Publ) with notifications on news.